HRMY
Price
$38.04
Change
+$0.87 (+2.34%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
2.14B
69 days until earnings call
SNBIF
Price
$16.45
Change
+$2.17 (+15.20%)
Updated
Aug 6 closing price
Capitalization
1.17B
Interact to see
Advertisement

HRMY vs SNBIF

Header iconHRMY vs SNBIF Comparison
Open Charts HRMY vs SNBIFBanner chart's image
Harmony Biosciences Holdings
Price$38.04
Change+$0.87 (+2.34%)
Volume$1.85K
Capitalization2.14B
Sanbio
Price$16.45
Change+$2.17 (+15.20%)
Volume$500
Capitalization1.17B
HRMY vs SNBIF Comparison Chart in %
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. SNBIF commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a StrongBuy and SNBIF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (HRMY: $37.17 vs. SNBIF: $16.45)
Brand notoriety: HRMY and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRMY: 47% vs. SNBIF: 120%
Market capitalization -- HRMY: $2.14B vs. SNBIF: $1.17B
HRMY [@Biotechnology] is valued at $2.14B. SNBIF’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than SNBIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 6 TA indicator(s) are bullish while SNBIF’s TA Score has 2 bullish TA indicator(s).

  • HRMY’s TA Score: 6 bullish, 3 bearish.
  • SNBIF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than SNBIF.

Price Growth

HRMY (@Biotechnology) experienced а +2.12% price change this week, while SNBIF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.93%. For the same industry, the average monthly price growth was +13.93%, and the average quarterly price growth was +30.97%.

Reported Earning Dates

HRMY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+3.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($2.14B) has a higher market cap than SNBIF($1.17B). SNBIF YTD gains are higher at: 253.763 vs. HRMY (8.021). HRMY has higher annual earnings (EBITDA): 265M vs. SNBIF (-2.99B). SNBIF has more cash in the bank: 3.96B vs. HRMY (565M). HRMY has less debt than SNBIF: HRMY (172M) vs SNBIF (598M). HRMY has higher revenues than SNBIF: HRMY (773M) vs SNBIF (0).
HRMYSNBIFHRMY / SNBIF
Capitalization2.14B1.17B182%
EBITDA265M-2.99B-9%
Gain YTD8.021253.7633%
P/E Ratio11.99N/A-
Revenue773M0-
Total Cash565M3.96B14%
Total Debt172M598M29%
FUNDAMENTALS RATINGS
SNBIF: Fundamental Ratings
SNBIF
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYSNBIF
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
14%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
14%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
8%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
15%
View a ticker or compare two or three
Interact to see
Advertisement
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFDPX40.260.18
+0.45%
DF Dent Premier Growth Investor
QUERX21.690.02
+0.09%
AQR Large Cap Defensive Style R6
BIAHX18.41N/A
N/A
Brown Advisory WMC Strat Eurp Eq Inv
LMESX38.04N/A
N/A
ClearBridge Appreciation IS
CONWX18.67N/A
N/A
Concorde Wealth Management

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-0.67%
SNBIF - HRMY
52%
Loosely correlated
N/A
CYTK - HRMY
37%
Loosely correlated
+3.19%
ANAB - HRMY
37%
Loosely correlated
-0.70%
LGND - HRMY
32%
Poorly correlated
+0.61%
AXON - HRMY
31%
Poorly correlated
+0.72%
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with HRMY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then HRMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
HRMY - SNBIF
52%
Loosely correlated
-0.67%
QRON - SNBIF
34%
Loosely correlated
N/A
CING - SNBIF
28%
Poorly correlated
+2.26%
WXXWY - SNBIF
28%
Poorly correlated
-1.18%
EDSA - SNBIF
25%
Poorly correlated
+0.41%
More